Evidence

The use of IQoro in treating medical conditions is supported by scientific and clinical evidence. Below are links to details of this evidence.

Scientific studies

There is a sequence of internationally published papers that show the evolution from early research into neuromuscular treatment through to the evidence for IQoro in clinical studies in treating dysphagia, Hiatal hernia and other conditions. 

Read Scientific articles

Read a Summary of Studies

Book chapters

The following two book chapters were published in 2021 and provide detailed explanations of the neurology of the swallow and more.

Service Evaluation

A Service Evaluation conducted by the Royal Devon and Exeter NHS Trust and supported by the South West Academic Science Network specifically evaluated the suitability of IQoro in treating patients in NHS acute, in-patient rehab, and community settings.

Treating children with Cerebral Palsy

A UK SLT has researched saliva control dysfunction in children and young people with Cerebral Palsy using practice-based evidence outcome measures.

NICE Medtech Innovation Briefings

In late 2018 the company submitted evidence to NICE that resulted in two Medtech Innovation Briefings (MIBs) being issued. These referenced IQoro as a treatment for Dysphagia after Stroke, and for treating Hiatus hernia. At the time of publication, more research was desirable, evidence of its successful use in NHS settings has since been addressed.

Read more